Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands

Treatment options for ADHD in the Netherlands have increased with the introduction of the extended-release formulations of methylphenidate (MPH ER, Concerta(®)) in 2003 and atomoxetine (ATX, Strattera(®)) in 2005, but data on the effect on drug usage patterns are scarce. The objective of the present...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: van den Ban, Els, Souverein, Patrick C., Swaab, Hanna, van Engeland, Herman, Egberts, Toine C. G., Heerdink, Eibert R.
Format: Artigo
Jezik:Inglês
Izdano: Springer Vienna 2010
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3000908/
https://ncbi.nlm.nih.gov/pubmed/21258431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12402-010-0044-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki